Rufine Akué‐Gédu
Rufine Akué‐Gédu publishes mostly in Organic Chemistry, Molecular Biology and Pathology and Forensic Medicine, on topics such as Cancer Mechanisms and Therapy, Phytochemical compounds biological activities and Synthesis and Biological Activity.
- World rank
- #5,389,163 of 7,710,434 ranked researchers
- Rank in France
- #228,123 of 324,115
- Works
- 39
- Citations
- 441
- Citations per work
- 11.3
What does Rufine Akué‐Gédu research?
Rufine Akué‐Gédu's work is mostly in Chemistry (47%), Biochemistry, Genetics and Molecular Biology (29%), Medicine (16%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Physical Sciences1846.9%
- Chemistry1846.9%
- Life Sciences1129.2%
- Health Sciences615.7%
- Medicine615.7%
- Everything else38.2%
- 1Organic Chemistry43% of their works
- 2Molecular Biology23% of their works
- 3Pathology and Forensic Medicine12% of their works
- 4Cancer Research6% of their works
- 5Oncology4% of their works
- 6Spectroscopy4% of their works
Research topics
- Cancer Mechanisms and Therapy
- Phytochemical compounds biological activities
- Synthesis and Biological Activity
- Synthesis and biological activity
- Synthesis and bioactivity of alkaloids
- Asymmetric Synthesis and Catalysis
- Synthesis and Reactivity of Heterocycles
- Synthesis and pharmacology of benzodiazepine derivatives
Which keywords describe Rufine Akué‐Gédu's research?
The keywords of their largest research topics: Asymmetric Synthesis, Pharmacology, Synthesis, Bioactivity, Anticancer Agents, DNA Binding, Pim Oncogenes and Tumorigenesis.
- Organocatalysis
- Fluorescent Probes
- DNA-Interactive Agents
- Beta-Carboline Alkaloids
- Tetrahydroisoquinoline
- Ecteinascidin
- Limonoids
- Cytotoxicity
- Tumorigenesis
- DNA Binding
- Bioactivity
- Pharmacology
- Asymmetric Synthesis
- Synthesis
- Anticancer Agents
- Pim Oncogenes
- Heterocyclic Compounds
- Biological Evaluation
- Medicinal Plants
- Medicinal Chemistry
- Tubulin Inhibitors
- Pharmacological Functions
- Enantioselective Reactions
- Indolizines
- Pyrrolobenzodiazepines
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 25 words, with their numbers
- Asymmetric Synthesis143 topics
- Pharmacology142 topics
- Synthesis133 topics
- Bioactivity122 topics
- Anticancer Agents112 topics
- DNA Binding112 topics
- Pim Oncogenes111 topic
- Tumorigenesis111 topic
- Heterocyclic Compounds102 topics
- Cytotoxicity92 topics
- Biological Evaluation82 topics
- Limonoids81 topic
- Medicinal Plants81 topic
- Ecteinascidin61 topic
- Medicinal Chemistry61 topic
- Tetrahydroisoquinoline61 topic
- Tubulin Inhibitors61 topic
- Beta-Carboline Alkaloids51 topic
- Pharmacological Functions51 topic
- DNA-Interactive Agents41 topic
- Enantioselective Reactions41 topic
- Fluorescent Probes41 topic
- Indolizines41 topic
- Organocatalysis41 topic
- Pyrrolobenzodiazepines41 topic
Where does Rufine Akué‐Gédu work?
Rufine Akué‐Gédu's main affiliation in the publication record is Hautes Études d'Ingénieur, France.
How many publications and citations does Rufine Akué‐Gédu have?
OpenAlex counts 39 works and 441 citations for Rufine Akué‐Gédu, an h-index of 10, ranking #5,389,163 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Rufine Akué‐Gédu. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.